SEC Form 4 · accession 0001209191-15-006039
Phio Pharmaceuticals Corp. · PHIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Bitterman
Director
Period of report
Jan 22, 2015
Accepted (ET)
Jan 23, 2015 · 8:50 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001533040
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value | Jan 22, 2015 | P | 3,147 | $1.20 | A | 4,647 | D | |
| Common stock, $0.0001 par value | Jan 22, 2015 | P | 1,853 | $1.19 | A | 6,500 | D |
Table II — derivative securities
No Table II lines on this filing.